ST
Satyendra Tiwari
About Satyendra Tiwari
Data last updated:
Satyendra Tiwari is an Additional Director at S.S. Pharma Traders Private Limited (since 2025), Director at Dhanvanthri Super Speciality Private Limited (since 2025) and Director at Devi Pharma Wellness Private Limited (since 2025), and holds 3 more current directorships. The companies operate in Pharma and Healthcare. The 6 current companies with reported revenue have a combined latest revenue of ₹469 Cr; the largest is S.S. Pharma Traders Private Limited at ₹130 Cr (FY 2025). Earlier, Satyendra Tiwari was an Additional Director at R S M Pharma Private Limited (2025) and Additional Director at Avenues Pharma Distributors Private Limited (2025) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 S.S. Pharma Traders Private Limited U85300UP2022PTC168228 | Additional Director | 07 Oct 2025 | 2022 | ₹130 Cr (FY 2025) | Active |
| Dhanvanthri Super Speciality Private Limited U46497KA2023PTC177243 | Director | 26 May 2025 | 2023 | ₹126 Cr (FY 2025) | Active |
| Devi Pharma Wellness Private Limited U46497KL2024PTC088322 | Director | 26 May 2025 | 2024 | ₹112 Cr (FY 2025) | Active |
| Avenir Lifecare Pharma Private Limited U46497TS2023PTC177827 | Director | 01 Jul 2024 | 2023 | ₹55.34 Cr (FY 2025) | Active |
| Srinivasa Lifecare Private Limited U46497TS2024PTC187272 | Director | 26 May 2025 | 2024 | ₹33.05 Cr (FY 2025) | Active |
| Ujjain Maheshwari Pharma Distributors Private Limited U46497MP2024PTC071761 | Director | 24 May 2025 | 2024 | ₹11.56 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 R S M Pharma Private Limited U85110KA1989PTC009974 | Additional Director | 24 Jan 2025 | 1989 | ₹363 Cr (FY 2025) | Active |
| Avenues Pharma Distributors Private Limited U24239KA2019PTC122720 | Additional Director | 24 Jan 2025 | 2019 | ₹279 Cr (FY 2025) | Active |
| Quromed Lifesciences Private Limited U51100MH2020PTC339126 | Additional Director | 10 Feb 2025 | 2020 | Strike Off | |
| Rimedio Pharma Private Limited U51909MH2020PTC339123 | Additional Director | 10 Feb 2025 | 2020 | Strike Off | |
| Zennx Software Solutions Private Limited U72900MH2021PTC371067 | Additional Director | 31 Jan 2025 | 2021 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Satyendra Tiwari
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satyendra Tiwari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satyendra Tiwari
Satyendra Tiwari currently holds 6 directorships: S.S. Pharma Traders Private Limited (Additional Director, since 07 Oct 2025, revenue ₹130 Cr (FY 2025)); Dhanvanthri Super Speciality Private Limited (Director, since 26 May 2025, revenue ₹126 Cr (FY 2025)); Devi Pharma Wellness Private Limited (Director, since 26 May 2025, revenue ₹112 Cr (FY 2025)); Avenir Lifecare Pharma Private Limited (Director, since 01 Jul 2024, revenue ₹55.34 Cr (FY 2025)); Srinivasa Lifecare Private Limited (Director, since 26 May 2025, revenue ₹33.05 Cr (FY 2025)); and 1 more.
Satyendra Tiwari was first appointed on 01 Jul 2024 as Director at Avenir Lifecare Pharma Private Limited. The most recent appointment on record is 07 Oct 2025 at S.S. Pharma Traders Private Limited.
The 6 current companies of Satyendra Tiwari that report revenue have a combined latest revenue of ₹469 Cr: S.S. Pharma Traders Private Limited ₹130 Cr (FY 2025); Dhanvanthri Super Speciality Private Limited ₹126 Cr (FY 2025); Devi Pharma Wellness Private Limited ₹112 Cr (FY 2025); Avenir Lifecare Pharma Private Limited ₹55.34 Cr (FY 2025); Srinivasa Lifecare Private Limited ₹33.05 Cr (FY 2025); and 1 more.
Satyendra Tiwari held 5 earlier board appointments: R S M Pharma Private Limited (Additional Director, 24 Jan 2025 to 26 May 2025); Avenues Pharma Distributors Private Limited (Additional Director, 24 Jan 2025 to 26 May 2025); Quromed Lifesciences Private Limited (Additional Director, from 10 Feb 2025); Rimedio Pharma Private Limited (Additional Director, from 10 Feb 2025); Zennx Software Solutions Private Limited (Additional Director, from 31 Jan 2025).
The current boards of Satyendra Tiwari's companies include Sambit Mohanty (S.S. Pharma Traders Private Limited), Shahbaz Ahmad Siddiqui (S.S. Pharma Traders Private Limited), Bhavya Balaraj (Dhanvanthri Super Speciality Private Limited), Guttahalli Krishnappa Shridhar (Dhanvanthri Super Speciality Private Limited), Kushal Ashok Shah (Dhanvanthri Super Speciality Private Limited), Manish Kumar (Dhanvanthri Super Speciality Private Limited), among others.